VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases

E-ISSN： 2212-3873|15|2|135-144

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.15, Iss.2, 2015-06, pp. : 135-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evolving Strategies in Manipulating VEGF/VEGFR Signaling for the Promotion of Angiogenesis in Ischemic Muscle

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 411-421

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-01 ,pp. : 624-653

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF/VEGFR₂ Signaling Regulates Germ Cell Proliferation in vitro and Promotes Mouse Testicular Regeneration in vivo

Cells Tissues Organs, Vol. 201, Iss. 1, 2015-0 ,pp. : 1-13

Karger

Access to resources Recommend Favorite

The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway

Current Clinical Pharmacology, Vol. 3, Iss. 2, 2008-05 ,pp. : 132-143

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis

Current Drug Targets, Vol. 16, Iss. 2, 2015-01 ,pp. : 164-170

Bentham Science Publishers

Access to resources Recommend Favorite